AngioDynamics Inc. (NASDAQ: ANGO) has reported a wider net loss for the third quarter of 2024 when the medical device maker’s revenue declined. The company also issued guidance for fiscal 2024. Net loss, excluding special items, was $0.16 per share in the February quarter, compared to a loss of $0.03 ...
alphastreetusx:ango
